Abstract
Cells from patients with the human genetic disorder ataxia-telangiectasia (A-T) are defective in the activation of cell cycle checkpoints in response to ionizing radiation damage. In order to understand the role of ATM in checkpoint control we investigated whether Schizosaccaromyces pombe chk1, a protein kinase implicated in controlling the G2 DNA damage checkpoint, might alter the radiosensitive phenotype in A-T cells. The fission yeast chk1 gene was cloned into an EBV-based vector under the control of a metallothionein promoter and transfected into A-T lymphoblastoid cells. Induction of chk1 enhanced the survival of an A-T cell line in response to radiation exposure as determined by cell viability and reduction of radiation-induced chromosome aberrations. This can be accounted for at least in part by the restoration of the G2 checkpoint to chk1 expressing cells. There was no evidence that chk1 expression corrected either the G1/S checkpoint or radioresistant DNA synthesis in S phase in these cells. These results suggest that chk1 when overexpressed acts downstream from ATM to restore the G2 checkpoint in these cells and correct the radiosensitive phenotype. These data allow us to dissociate individual checkpoint events and relate them to the radiosensitive phenotype in A-T cells.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Al-Khodairy F and Carr AM. . 1992 EMBO J. 11: 1343–1350.
Al-Khodairy F, Foton E, Sheldrick KS, Griffiths DIF, Lehmann AR and Carr AM. . 1994 Mol. Biol. Cell 5: 147–160.
Badie CG, Iiiakis N, Foray G, Alsbeih B, Pantelias R, Okayasu N, Cheong NS, Russel AC, Begg CF, Arlett CF and Malaise EP. . 1995 Cancer Res. 55: 1232–1234.
Baskaran R, Wood LD, Whitaker LL, Canman CE, Morgan SE, Zu Y, Barlow C, Baltimore D, Wynshaw-Boris A, Kastan MB and Wang JYJ. . 1997 Nature 387: 516–520.
Bates PR, Imray FP and Lavin MF. . 1985 Int. J. Radiat. Biol. 47: 713–722.
Beamish H and Lavin MF. . 1994 Int. J. Radiat. Biol. 65: 175–184.
Beamish H, Williams R, Chen P and Lavin MF. . 1996 J. Biol. Chem. 271: 20486–20493.
Bentley NJ, Holtzman DA, Flaggs G, Keegan KS, DeMaggio A, Ford JC, Hoekstra M and Carr AM. . 1996 EMBO J. 15: 6641–6651.
Canman CE, Wolff AC, Chen CY, Fornace Jr AJ and Kastan MB. . 1994 Cancer Res. 54: 5054–5058.
Chen PC, Lavin MF, Kidson C and Moss D. . 1978 Nature 274: 484–486.
Chen P, Girges AA, Hobson K, Beamish H, Khanna KK, Farrell A, Gatei M, Teale B, Buchwald M, Legerski R and Lavin MF. . 1996 Int. J. Radiat. Biol. 69: 385–395.
Cimprich KA, Shin TB, Keith CT and Schreiber SL. . 1996 Proc. Natl. Acad. Sci. USA 93: 2850–2855.
Clarke AR, Purdie CA, Harrison DJ, Morris RG, Bird CC, Hooper M and Wylie AH. . 1993 Nature 362: 849–852.
Cliby WA, Roberts CS, Cimprich KA, Stringer CM, Lamb JR, Schreiber SL and Friend SH. . 1998 EMBO J. 17: 159–169.
Cornforth MW and Bedford JS. . 1985 Science 227: 1589–1591.
Dulic V, Kaufmann WK, Wilson SJ, Tisty TD, Lees E, Wade Harper J, Elledge SJ and Reed SI. . 1994 Cell 76: 1013–1023.
Flaggs G, Plug AW, Dunks KM, Mundt KE, Ford JC, Quiggle MRE, Taylor EM, Wetphal CH, Ashley T, Hoekstra MF and Carr AM. . 1997 Curr. Biol. 7: 977–986.
Ford JC, Al-Khordairy F, Fotou E, Sheldrick KS, Griffiths DJF and Carr AM. . 1994 Science 265: 533–535.
Furnari B, Rhind N and Russell P. . 1997 Science 277: 1495–1497.
Gotoff SP, Amirmokri E and Liebner EJ. . 1967 Am. J. Dis. Child 114: 617–625.
Honda R, Ohba Y and Yasuda H. . 1997 Biochem. Biophys. Res. Comm. 230: 262–265.
Houldsworth J and Lavin MF. . 1980 Nucleic Acids Res. 8: 3709–3720.
Jimenez G, Yucel J, Rowley R and Subramani S. . 1992 Proc. Natl. Acad. Sci. USA 89: 4952–4956.
Kastan MB, Onyekwere O, Sidransky D, Vogelstein B and Craig RW. . 1991 Cancer Res. 51: 6304–6311.
Kastan MB, Zhan O, EL-Deiry WS, Carrier F, Jacks T, Walsh WV, Plunkett BS, Vogelstein B and Fornace AJ. . 1992 Cell 71: 587–597.
Keegan KS, Holtzman DA, Plug AW, Christenson ER, Brainerd EE, Flaggs G, Bentley NJ, Taylor EM, Meyn MS, Moss SB, Carr AM, Ashley T and Hoekstra MF. . 1996 Genes and Dev. 10: 2423–2437.
Khanna KK and Lavin MF. . 1993 Oncogene 8: 3307–3312.
Khanna KK, Beamish H, Yan J, Hobson K, Williams R, Dunn I and Lavin MF. . 1995 Oncogene 11: 609–618.
Khanna KK, Shafman T, Kedar P, Spring K, Kozlov S, Yen T, Hobson K, Gatei M, Zhang N, Watters D, Egerton M, Shiloh Y, Kharbanda S, Kufe D and Lavin MF. . 1997 Nature 387: 520–523.
Konig K and Baisch H. . 1980 Radiat. Environ. Biophys. 18: 257–265.
Lavin MF, Khanna KK, Beamish H, Spring K, Watters D and Shiloh Y. . 1995 TIBS 20: 382–383.
Lavin MF and Shiloh Y. . 1997 Ann. Rev. Immunol. 15: 177–202.
Lee JH and Bernstein A. . 1993 Proc. Natl. Acad. Sci. USA 90: 5742–5746.
Leeper DB, Schneidermann MH and Dewey DC. . 1972 Radiat. Res. 50: 410–407.
Lehmann AR, Arlett CF, Burke JF, Green MHL, James MR and Lowe JE. . 1986 Int. J. Radiat. Biol. 49: 639–643.
Li R and Murray AW. . 1991 Cell 66: 519–531.
Lowe S, Schmitt E, Smith S, Osborne B and Jacks T. . 1993 Nature 362: 847–849.
Morgan JL, Holcomb TM and Morrissey RW. . 1968 Am. J. Dis. Child 116: 557–558.
Nagasawa H and Little JB. . 1983 Mutat. Res. 109: 297–308.
O'Connell MJ, Raleigh JM, Verkade HM and Nurse P. . 1997 EMBO J. 16: 545–554.
Ogg S, Gabrielli B and Piwinica-Worms H. . 1994 J. Biol. Chem 269: 30461–30469.
Painter RB and Young BR. . 1980 Proc. Natl. Acad. Sci. USA 77: 7315–7317.
Peng C-Y, Graves PR, Thoma RS, Wu Z, Shaw AS and Piwnica-Worms H. . 1997 Science 277: 1501–1505.
Rhind N, Furnari B and Russell P. . 1997 Genes and Dev. 11: 504–511.
Rotman G and Shiloh Y. . 1997 Bioessays 19: 911–917.
Sanchez Y, Wong C, Thoma RS, Richman R, Wu Z, Pixnica-Worms H and Elledge E. . 1997 Science 277: 1497–1501.
Savitsky K, Bar-Shira A, Gilad S, Rotman G, Ziv Y, Vanagaite L, Tagle DA, Smith S, Uziel T, Sfez S, Ashkenazi M, Pecker I, Frydman M, Harnik R, Patanjali SR, Simmons A, Clines GA, Sartiel A, Gatti RA, Chessa L, Sanal O, Lavin MF, Jaspers NGJ, Taylor AMR, Arlett CF, Miki T, Weissman SM, Lovett M, Collins FS and Shiloh Y. . 1995 Science 268: 1749–1753.
Sedgwick RP and Boder E. . 1991 Ataxia-telangiectasia (208900; 208910; 208920). In: Hereditary Neuropthaies and Spinocerebellar Atrophies JMB Vianney De Jong (ed.). Elsevier Science Publishers:Amsterdam pp.347–423.
Slichenmyer WJ, Nelson WG, Slebos RJ and Kastan MB. . 1993 Cancer Res. 53: 4164–4168.
Taylor AM, Harnden DG, Arlett CF, Harcourt SA, Lehmann AR, Stevens S and Bridges BA. . 1975 Nature 4: 427–429.
Vousden KH, Crook T and Farrell PJ. . 1993 J. Gen. Virol. 74: 803–810.
Walworth N, Davey S and Beach D. . 1993 Nature 363: 368–371.
Walworth NC and Bernards R. . 1996 Science 271: 353–356.
Weinert TA and Hartwell LH. . 1990 Mol. Cell. Biol. 10: 6554–6564.
Westphal CH. . 1997 Curr. Biol. 7: R789–R792.
Zakian VA. . 1995 Cell 82: 685–687.
Zampetti-Bossler F and Scott D. . 1981 Int. J. Radiat. Biol. 39: 547–558.
Zhang N, Chen P, Khanna KK, Scott S, Gatei M, Kozlov S, Watters D, Spring K, Yen T and Lavin MF. . 1997 Proc. Natl. Acad. Sci. USA 94: 8021–8026.
Acknowledgements
We wish to thank the Australian National Health and Medical Research Council, the National Institutes of Health USA and the Tzu Chi Foundation for support. Aine Farrell is acknowledged for cell culture work and Ann Knight for word-processing.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Chen, P., Gatei, M., O'Connell, M. et al. Chk1 complements the G2/M checkpoint defect and radiosensitivity of ataxia-telangiectasia cells. Oncogene 18, 249–256 (1999). https://doi.org/10.1038/sj.onc.1202257
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1202257
Keywords
This article is cited by
-
Involvement of novel autophosphorylation sites in ATM activation
The EMBO Journal (2006)
-
Cellular responses to ionising radiation of AT heterozygotes: differences between missense and truncating mutation carriers
British Journal of Cancer (2004)
-
Disruption of the BLM gene in ATM-null DT40 cells does not exacerbate either phenotype
Oncogene (2004)
-
Radiation-induced Phosphorylation of Chk1 at S345 is Associated with p53-dependent Cell Cycle Arrest Pathways
Neoplasia (2002)
-
Blocking CHK1 Expression Induces Apoptosis and Abrogates the G2 Checkpoint Mechanism
Neoplasia (2001)